MNOV – Medicinova Inc
MediciNova, Inc.MNOV
$1.31Name : MediciNova, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $64,493,000.00
EPSttm : -0.23
MediciNova, Inc.
$1.31
1.50%$0.02Float Short %
0.35
Margin Of Safety %
Put/Call OI Ratio
EPS Next Q Diff
EPS Last/This Y
-0.27
EPS This/Next Y
0.12
Price
1.33
Target Price
7
Analyst Recom
1
Performance Q
-9.66
Relative Volume
0.71
Beta
0.4
Ticker: MNOV
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-06-02 | MNOV | 1.4093 | 0.07 | 0.00 | 143 |
| 2025-06-03 | MNOV | 1.44 | 0.07 | 0.00 | 143 |
| 2025-06-04 | MNOV | 1.42 | 0.07 | 0.00 | 143 |
| 2025-06-05 | MNOV | 1.4 | 0.07 | 0.00 | 143 |
| 2025-06-06 | MNOV | 1.42 | 0.07 | 0.00 | 143 |
| 2025-06-09 | MNOV | 1.41 | N/A | N/A | 0 |
| 2025-06-10 | MNOV | 1.41 | 0.06 | 0.00 | 153 |
| 2025-06-11 | MNOV | 1.38 | 0.06 | 0.00 | 153 |
| 2025-06-12 | MNOV | 1.35 | 0.06 | 999.99 | 166 |
| 2025-06-13 | MNOV | 1.33 | 0.06 | 999.99 | 166 |
| 2025-06-16 | MNOV | 1.33 | 0.06 | 999.99 | 166 |
| 2025-06-17 | MNOV | 1.27 | 0.06 | 999.99 | 166 |
| 2025-06-18 | MNOV | 1.29 | 0.06 | 999.99 | 166 |
| 2025-06-20 | MNOV | 1.25 | N/A | N/A | 0 |
| 2025-06-23 | MNOV | 1.32 | N/A | N/A | 0 |
| 2025-06-24 | MNOV | 1.35 | N/A | N/A | 0 |
| 2025-06-25 | MNOV | 1.34 | N/A | N/A | 0 |
| 2025-06-26 | MNOV | 1.2901 | N/A | N/A | 0 |
| 2025-06-27 | MNOV | 1.32 | N/A | N/A | 0 |
| 2025-06-30 | MNOV | 1.31 | N/A | N/A | 0 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-06-02 | MNOV | 1.41 | - | - | -0.50 |
| 2025-06-03 | MNOV | 1.41 | - | - | -0.50 |
| 2025-06-04 | MNOV | 1.43 | - | - | -0.50 |
| 2025-06-05 | MNOV | 1.39 | - | - | -0.50 |
| 2025-06-06 | MNOV | 1.41 | - | - | -0.50 |
| 2025-06-09 | MNOV | 1.42 | - | - | -0.50 |
| 2025-06-10 | MNOV | 1.42 | - | - | -0.50 |
| 2025-06-11 | MNOV | 1.38 | - | - | -0.50 |
| 2025-06-12 | MNOV | 1.38 | - | - | -0.50 |
| 2025-06-13 | MNOV | 1.38 | - | - | -0.50 |
| 2025-06-16 | MNOV | 1.33 | - | - | -0.50 |
| 2025-06-17 | MNOV | 1.26 | - | - | -0.50 |
| 2025-06-18 | MNOV | 1.27 | - | - | -0.50 |
| 2025-06-20 | MNOV | 1.29 | - | - | -0.50 |
| 2025-06-23 | MNOV | 1.32 | - | - | -0.50 |
| 2025-06-24 | MNOV | 1.35 | - | - | -0.50 |
| 2025-06-25 | MNOV | 1.34 | - | - | -0.50 |
| 2025-06-26 | MNOV | 1.29 | - | - | -0.50 |
| 2025-06-27 | MNOV | 1.32 | - | - | -0.50 |
| 2025-06-30 | MNOV | 1.33 | - | - | -0.50 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-06-02 | MNOV | 0.00 | -0.55 | 0.39 |
| 2025-06-03 | MNOV | 0.00 | -0.55 | 0.39 |
| 2025-06-04 | MNOV | 0.00 | -0.55 | 0.39 |
| 2025-06-05 | MNOV | 0.00 | -0.55 | 0.39 |
| 2025-06-06 | MNOV | 0.00 | -0.55 | 0.39 |
| 2025-06-09 | MNOV | 0.00 | -0.55 | 0.39 |
| 2025-06-11 | MNOV | 0.00 | -0.55 | 0.36 |
| 2025-06-12 | MNOV | 0.00 | -0.55 | 0.36 |
| 2025-06-13 | MNOV | 0.00 | -0.55 | 0.36 |
| 2025-06-16 | MNOV | 0.00 | -0.56 | 0.36 |
| 2025-06-17 | MNOV | 0.00 | -0.56 | 0.36 |
| 2025-06-18 | MNOV | 0.00 | -0.56 | 0.36 |
| 2025-06-19 | MNOV | 0.00 | -0.56 | 0.36 |
| 2025-06-20 | MNOV | 0.00 | -0.56 | 0.36 |
| 2025-06-24 | MNOV | 0.00 | -0.55 | 0.36 |
| 2025-06-25 | MNOV | 0.00 | -0.55 | 0.36 |
| 2025-06-26 | MNOV | 0.00 | -0.55 | 0.35 |
| 2025-06-27 | MNOV | 0.00 | -0.55 | 0.35 |
| 2025-06-30 | MNOV | 0.00 | -0.55 | 0.35 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
Avg. EPS Est. Current Quarter
-0.12
Avg. EPS Est. Next Quarter
-0.12
Insider Transactions
Institutional Transactions
-0.55
Beta
0.4
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
12
Growth Score
21
Sentiment Score
87
Actual DrawDown %
90
Max Drawdown 5-Year %
-89.7
Target Price
7
P/E
Forward P/E
PEG
P/S
P/B
1.29
P/Free Cash Flow
EPS
-0.23
Average EPS Est. Cur. Y
-0.5
EPS Next Y. (Est.)
-0.38
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
Relative Volume
0.71
Return on Equity vs Sector %
-46.2
Return on Equity vs Industry %
-27.1
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
MediciNova, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 13
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company develops MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent in Phase 2b/3 clinical trial for treating neurological and other disorders, such as progressive multiple sclerosis, amyotrophic lateral sclerosis, chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and substance dependence and addiction, as well as prevention of acute respiratory distress syndrome, and long COVID. It is also developing MN-001 (tipelukast), an orally bioavailable small molecule compound in Phase 2 clinical trial to treat fibrotic and other metabolic disorders, including nonalcoholic fatty liver disease and hypertriglycedemia. The company has a license agreement with Kyorin Pharmaceuticals for the development and commercialization of MN-166 and MN-001. MediciNova, Inc. was incorporated in 2000 and is headquartered in La Jolla, California.
stock quote shares MNOV – Medicinova Inc Stock Price stock today
news today MNOV – Medicinova Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch MNOV – Medicinova Inc yahoo finance google finance
stock history MNOV – Medicinova Inc invest stock market
stock prices MNOV premarket after hours
ticker MNOV fair value insiders trading